Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


31.07.2017

1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
4 Arch Phys Med Rehabil
1 Clin Ther
1 Eur Neurol
1 J Neurol Neurosurg Psychiatry
4 Mult Scler
1 Nat Rev Neurol
4 Neurology
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. ANDERSEN O, Hildeman A, Longfils M, Tedeholm H, et al
    Diffusion tensor imaging in multiple sclerosis at different final outcomes.
    Acta Neurol Scand. 2017 Jul 25. doi: 10.1111/ane.12797.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. EICHINGER P, Kirschke JS, Hoshi MM, Zimmer C, et al
    Pre- and Postcontrast 3D Double Inversion Recovery Sequence in Multiple Sclerosis: A Simple and Effective MR Imaging Protocol.
    AJNR Am J Neuroradiol. 2017 Jul 27. doi: 10.3174/ajnr.A5329.
    PubMed     Text format     Abstract available


    Arch Phys Med Rehabil

  3. KRATZ AL, Murphy SL, Braley TJ
    Ecological momentary assessment of pain, fatigue, depressive and cognitive symptoms reveals significant daily variability in multiple sclerosis.
    Arch Phys Med Rehabil. 2017 Jul 17. pii: S0003-9993(17)30465.
    PubMed     Text format     Abstract available

  4. KRATZ AL, Murphy SL, Braley TJ
    Pain, fatigue, and cognitive symptoms are temporally associated within- but not across-days in multiple sclerosis.
    Arch Phys Med Rehabil. 2017 Jul 17. pii: S0003-9993(17)30466.
    PubMed     Text format     Abstract available

  5. KRATZ AL, Braley TJ, Foxen-Craft E, Scott E, et al
    How do pain, fatigue, depressive, and cognitive symptoms relate to well-being and social and physical functioning in the daily lives of individuals with multiple sclerosis?
    Arch Phys Med Rehabil. 2017 Jul 17. pii: S0003-9993(17)30467.
    PubMed     Text format     Abstract available

  6. KARGARFARD M, Shariat A, Ingle L, Cleland JA, et al
    A randomized controlled trial to examine the impact of aquatic exercise training on functional capacity, balance, and perceptions of fatigue in female patients with multiple sclerosis.
    Arch Phys Med Rehabil. 2017 Jul 20. pii: S0003-9993(17)30471.
    PubMed     Text format     Abstract available


    Clin Ther

  7. FERNANDEZ O, Giovannoni G, Fox RJ, Gold R, et al
    Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.
    Clin Ther. 2017 Jul 24. pii: S0149-2918(17)30765.
    PubMed     Text format     Abstract available


    Eur Neurol

  8. GRASSO MG, Broccoli M, Casillo P, Catani S, et al
    Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis.
    Eur Neurol. 2017;78.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  9. ZHOU Y, Graves JS, Simpson S Jr, Charlesworth JC, et al
    Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Jul 24. pii: jnnp-2017-315971.
    PubMed     Text format     Abstract available


    Mult Scler

  10. TANAKA M, Kinoshita M, Tanaka K
    Intermittent drug holidays in fingolimod therapy for multiple sclerosis.
    Mult Scler. 2017 Jul 1:1352458517722647. doi: 10.1177/1352458517722647.
    PubMed     Text format    

  11. ROLF L, Muris AH, Mathias A, Du Pasquier R, et al
    Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
    Mult Scler. 2017 Jul 1:1352458517722646. doi: 10.1177/1352458517722646.
    PubMed     Text format     Abstract available

  12. KJOLHEDE T, Siemonsen S, Wenzel D, Stellmann JP, et al
    Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?
    Mult Scler. 2017 Jul 1:1352458517722645. doi: 10.1177/1352458517722645.
    PubMed     Text format     Abstract available

  13. STAMPANONI BASSI M, Leocani L, Comi G, Iezzi E, et al
    Can pharmacological manipulation of LTP favor the effects of motor rehabilitation in multiple sclerosis?
    Mult Scler. 2017 Jul 1:1352458517721358. doi: 10.1177/1352458517721358.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  14. FEINSTEIN A
    Multiple sclerosis: Treatment of cognitive impairment in secondary progressive MS.
    Nat Rev Neurol. 2017 Jul 28. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurology

  15. NIELSEN NM, Munger KL, Stenager E, Ascherio A, et al
    Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
    Neurology. 2017;89:411.
    PubMed     Text format    

  16. XIA Z, Cheng Q, Li J
    Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
    Neurology. 2017;89:410-411.
    PubMed     Text format    

  17. ZARGHAMI A
    Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.
    Neurology. 2017;89:410.
    PubMed     Text format    

  18. HACOHEN Y, Mankad K, Chong WK, Barkhof F, et al
    Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
    Neurology. 2017;89:269-278.
    PubMed     Text format     Abstract available


    PLoS One

  19. BSTEH G, Ehling R, Walchhofer LM, Hegen H, et al
    Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.
    PLoS One. 2017;12:e0181458.
    PubMed     Text format     Abstract available

  20. KIM HH, Jeong IH, Hyun JS, Kong BS, et al
    Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    PLoS One. 2017;12:e0181758.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: